State Street Corporation 13D and 13G filings for Akebia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 09:45 am Sale | 2026-03-31 | 13G | AKEBIA THERAPEUTICS INC AKBA | STATE STREET CORPORATION STT | 11,614,006 4.300% | -2,073,555 (-15.15%) | Filing |
| 2026-02-09 06:16 am Purchase | 2025-12-31 | 13G | AKEBIA THERAPEUTICS INC AKBA | STATE STREET CORPORATION STT | 13,687,561 5.200% | 13,115,625 (+2293.20%) | Filing |
| 2023-01-20 08:55 am Sale | 2022-12-31 | 13G | AKEBIA THERAPEUTICS INC AKBA | STATE STREET CORPORATION STT | 571,936 0.310% | -11,171,525 (-95.13%) | Filing |
| 2022-02-10 1:23 pm Sale | 2021-12-31 | 13G | AKEBIA THERAPEUTICS INC AKBA | STATE STREET CORPORATION STT | 11,743,461 6.710% | -2,263,176 (-16.16%) | Filing |